PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17203757-13	2006	CONCLUSION: The Caelyx-TNFalpha combination was proven to increase the efficacy of Caelyx alone, with a very low toxicity.	liposomal doxorubicin	16-22	tumor necrosis factor	Homo sapiens	23-31	
35562182-7	2022	Multiple cycles of intravenous c-JO4 plus Doxil (four cycles, 4 weeks apart, simulating the treatment regimen in the clinical trial) elicited antibodies against c-JO4 that increased with each cycle and were accompanied by elevation of pro-inflammatory cytokines IL-6 and TNFalpha.	liposomal doxorubicin	42-47	tumor necrosis factor	Homo sapiens	271-279